(Q51628085)

8 April 2018

title

Evaluation of uncertainty parameters estimated by different population PK software and methods. (English)

1 reference

8 April 2018

0 references

Céline Dartois

1

1 reference

8 April 2018

Annabelle Lemenuel-Diot

2

1 reference

8 April 2018

Christian Laveille

3

1 reference

8 April 2018

Brigitte Tranchand

4

1 reference

8 April 2018

Michel Tod

5

1 reference

8 April 2018

Pascal Girard

6

1 reference

8 April 2018

publication date

10 January 2007

1 reference

8 April 2018

Journal of Pharmacokinetics and Pharmacodynamics

published in

1 reference

8 April 2018

volume

34

1 reference

8 April 2018

issue

3

1 reference

8 April 2018

page(s)

289-311

1 reference

8 April 2018

https://scigraph.springernature.com/pub.10.1007/s10928-006-9046-9

exact match

0 references

cites work

Model appropriateness and population pharmacokinetic modeling

1 reference

https://api.crossref.org/works/10.1007%2FS10928-006-9046-9

Stability and performance of a population pharmacokinetic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-006-9046-9

Use of prior information to stabilize a population data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-006-9046-9

An evaluation of point and interval estimates in population pharmacokinetics using NONMEM analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-006-9046-9

Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs.

21 January 2018

1 reference

12 December 2020

Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia

1 reference

12 December 2020

Estimation of uncertainty and variability in bacterial growth using Bayesian inference. Application to Listeria monocytogenes.

1 reference

12 December 2020

PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.

1 reference

12 December 2020

Population pharmacokinetics of trastuzumab in patients with HER2+ metastatic breast cancer

1 reference

12 December 2020

Comparison of ED, EID, and API criteria for the robust optimization of sampling times in pharmacokinetics.

1 reference

12 December 2020

Bayesian analysis of population PK/PD models: general concepts and software

1 reference

12 December 2020

Population pharmacokinetics of clofarabine, a second-generation nucleoside analog, in pediatric patients with acute leukemia

1 reference

12 December 2020

Effect of misspecification of the absorption process on subsequent parameter estimation in population analysis

1 reference

12 December 2020

The importance of modeling interoccasion variability in population pharmacokinetic analyses

1 reference

12 December 2020

Population pharmacokinetic analysis of pegylated human erythropoietin in rats

1 reference

12 December 2020

Further Developments of the Fisher Information Matrix in Nonlinear Mixed Effects Models with Evaluation in Population Pharmacokinetics

1 reference

12 December 2020

Pharmacokinetic/pharmacodynamic studies in drug product development

1 reference

12 December 2020

Evaluating pharmacokinetic/pharmacodynamic models using the posterior predictive check

1 reference

12 December 2020

Implementation of OSPOP, an algorithm for the estimation of optimal sampling times in pharmacokinetics by the ED, EID and API criteria.

1 reference

12 December 2020

Modelling of individual pharmacokinetics for computer-aided drug dosage

1 reference

12 December 2020

Comparing non-hierarchical models: application to non-linear mixed effects modeling

1 reference

12 December 2020

Fisher information matrix for non-linear mixed-effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics

1 reference

12 December 2020

Nonlinear mixed effects models for repeated measures data

1 reference

12 December 2020

Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides.

1 reference

12 December 2020

Estimation of population pharmacokinetics using the Gibbs sampler.

1 reference

12 December 2020

Pharmacokinetic/pharmacodynamic modeling in drug development

1 reference

12 December 2020

Clinical applications of pharmacokinetics and adaptive control.

1 reference

12 December 2020

Individualizing drug dosage regimens: roles of population pharmacokinetic and dynamic models, Bayesian fitting, and adaptive control

1 reference

12 December 2020

Robust optimal design for the estimation of hyperparameters in population pharmacokinetics.

1 reference

12 December 2020

Comparison of population pharmacokinetic modeling methods using simulated data: results from the Population Modeling Workgroup

1 reference

12 December 2020

10.1007/S10928-006-9046-9

Identifiers

DOI

1 reference

8 April 2018

1 reference

8 April 2018